Sarcopenia as potential biological substrate of long COVID-19 syndrome: prevalence, clinical features, and risk factors
Autore: Anna Maria Martone 1, Matteo Tosato 1, Francesca Ciciarello 1, Vincenzo Galluzzo 1, Maria Beatrice Zazzara 1, Cristina Pais 1,
Giulia Savera 1, Riccardo Calvani 1, Emanuele Marzetti 1, Maria Camprubi Robles 2, Maria Ramirez 2, Francesco Landi 1* & Gemelli Against COVID-19 Post-Acute Care Team
1 Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; 2 Research and Development, Abbott Nutrition, Granada, Spain
Sarcopenia as potential biological substrate of long COVID-19 syndrome: prevalence, clinical features, and risk factors